Liposomal Calcium: A Novel Nutraceutical Delivery Approach by West Bengal Chemical Industries Ltd., Kolkata, India

Liposomes have emerged as clinically approved supramolecular nutraceutical delivery systems, renowned for their ability to encapsulate therapeutic agents and enhance their pharmacokinetic and pharmacodynamic properties [1]. These nanocarriers provide a unique platform for targeted nutraceutical delivery, reducing systemic toxicity and increasing therapeutic eficacy [2]. Liposomal calcium plays a crucial role in improving calcium bioavailability and absorption, making it an effective supplement for bone health, muscle function, and cellular signaling. Encapsulation in liposomes enhances calcium stability, protects it from degradation, and facilitates targeted delivery to speciic tissues. This advanced formulation minimizes gastrointestinal discomfort and maximizes calcium uptake, addressing deiciencies more eficiently than conventional calcium supplements [3]. West Bengal Chemical Industries Ltd., Kolkata, India, has revolutionized this domain with the development of advanced liposomal calcium formulations. These innovative formulations are designed to exploit calcium's critical role in cellular signaling, disease progression, and tissue repair. The calcium liposomes manufactured by West Bengal Chemical Industries Ltd. are engineered to ensure stability, biocompatibility, and high selectivity, making them ideal for applications in treating conditions such as osteoporosis, calcium deiciency disorders, and cardiovascular diseases. The beneits of liposomal calcium include enhanced bioavailability, targeted delivery to affected tissues, and minimized side effects due to the controlled release mechanism

Read PDF

Mentioned Companies

West Bengal Chemical Industries Limited